[Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas].
Eight patients with T-cell-lymphoma of the skin (6 mycosis fungoides, 2 parapsoriasis variegata) were treated with Tigason in combination with PUVA-therapy. The daily dose of Tigason was 50-100 mg. There was complete regression of skin lesions in three patients, partial regression in three patients, and an improvement in two patients.
D003131:Combined Modality Therapy; D005050:Etretinate / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D009182:Mycosis Fungoides / Q000188:drug therapy / Q000628:therapy; D011701:PUVA Therapy; D010267:Parapsoriasis / Q000188:drug therapy / Q000628:therapy; D010778:Photochemotherapy; D012878:Skin Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes
D005050:Etretinate
Vorläufige Ergebnisse der Re-PUVA-Therapie bei kutanen T-Zell-Lymphomen.